Literature DB >> 25653095

A comparison of techniques to mitigate Simulator Adaptation Syndrome.

Germán Gálvez-García1.   

Abstract

We investigated the effectiveness of galvanic cutaneous stimulation (GCS) and auditory stimulation in mitigating simulator adaptation syndrome (SAS). Fifteen drivers (9 men; M age = 23.2 years) participated in a driving simulation experiment comparing three different stimulation conditions (GCS, auditory stimulation and no stimulation as a base line condition) in curves on a virtual urban circuit. GCS and auditory stimulation decreased SAS by reducing head sway. Both sources of stimulation can be recommended as countermeasures against SAS. We encourage the use of stimuli which influence the balancing ability to the design of future simulator protocols and devices to mitigate SAS. PRACTITIONER
SUMMARY: We have provided evidence on the effectiveness of two different stimuli as countermeasures against simulator adaptation syndrome (SAS). We concluded that the positive impact of body sway might play a role in SAS and therefore encourage the use of stimuli which influence the balancing ability to mitigate the symptoms of SAS.

Entities:  

Keywords:  auditory stimulation; driving task; galvanic cutaneous stimulation; simulator adaption syndrome; simulator sickness questionnaire

Mesh:

Year:  2015        PMID: 25653095     DOI: 10.1080/00140139.2015.1005168

Source DB:  PubMed          Journal:  Ergonomics        ISSN: 0014-0139            Impact factor:   2.778


  2 in total

1.  Evaluation of Driver's Reaction Time Measured in Driving Simulator.

Authors:  Kristián Čulík; Alica Kalašová; Vladimíra Štefancová
Journal:  Sensors (Basel)       Date:  2022-05-06       Impact factor: 3.847

2.  Joint and individual effectiveness of galvanic cutaneous stimulation and tactile stimulation at decreasing Simulator Adaptation Syndrome.

Authors:  Germán Gálvez-García; Javier Albayay; Fernando Fonseca; Claudio Bascour-Sandoval
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.